Alivus Life Sciences Ltd

Alivus Life Sciences Allots 55K Employee Stock Options 📈

- 55,000 equity shares allotted under 'Employee Stock Option Scheme, 2021'.

- Face value per share: ₹2.

- Paid-up capital rises from 12,26,81,348 shares (₹24,53,62,696) to 12,27,36,348 shares (₹24,54,72,696).

- Announcement date: January 21, 2026.

- Company now operates as Alivus Life Sciences Ltd (formerly Glenmark Life Sciences Ltd).